We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Soft Hydrogel Structures Developed for Organ Regeneration Studies

By LabMedica International staff writers
Posted on 25 Jan 2018
A team of British bioengineers has developed a novel cryogenics-based three-dimensional printing technique for producing soft biological structures that mimic the mechanical properties of organs such as the brain and lungs.

The technique, which was described in the November 24, 2017, online edition of the journal Scientific Reports, used dry ice in an isopropanol bath to rapidly cool a hydrogel ink as it was extruded from a three-dimensional printer. More...
The ink was a composite hydrogel of poly(vinyl) alcohol (PVA) and Phytagel (a water-soluble anionic polysaccharide produced by the bacterium Sphingomonas elodea). After being thawed, the gel that had been formed was as soft as body tissues, but did not collapse under its own weight, which had been a problem plaguing similar techniques in the past.

Having created the super soft hydrogel, the investigators at Imperial College London (United Kingdom) sought to: (i) provide mechanical evidence showing the three-dimensional printed material mimicked real brain tissue, providing the same response as the casted material, through unconfined compression tests, (ii) demonstrate the capabilities of this printing technique by achieving hollow three-dimensional printed structures, whose continuity through the layers had also been assessed using scanning electron microscopy (SEM) analysis, and (iii) evaluate the viability of cells in direct contact with the printed material.

The method was validated by showing that the three-dimensional printed materials were well matched to the cast-molded equivalents in terms of mechanical properties and microstructure. A preliminary biological evaluation on the three-dimensional printed material, coated with collagen type I, poly-L-lysine, and gelatin, was performed by seeding human dermal fibroblasts. Cells showed good attachment and viability on the collagen-coated three-dimensional printed hydrogel.

Senior author Dr. Antonio Elia Forte, a researcher in the department of bioengineering at Imperial College London, said, "Cryogenics is the novel aspect of this technology - it uses the phase change between liquid and solid to trigger polymerization and create super soft objects that can hold their shape. This means that the technology has a wide variety of possible uses."

Related Links:
Imperial College London


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Urinalysis Solution
UN-9000
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.